Rapamycin vs NMN

Head-to-head comparison of Rapamycin (Rapamycin (Sirolimus)) and NMN (Nicotinamide Mononucleotide) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyRapamycinNMN
CategoryAnti-AgingAnti-Aging
Full NameRapamycin (Sirolimus)Nicotinamide Mononucleotide
Molecular Weight914.17 Da334.22 Da
Half-Life~62 hoursN/A
Amino AcidsN/AN/A
Typical Dose0.5-6 mg/week250-1000 mg/day
RouteOralOral
Purity≥98%≥98%
Studies Count1500300
Research StatusClinicalClinical

Rapamycin Benefits

  • mTOR inhibition
  • autophagy activation
  • cellular senescence modulation
  • lifespan extension in model organisms

NMN Benefits

  • NAD+ support
  • mitochondrial function
  • DNA repair support
  • metabolic resilience

Rapamycin Dosing

0.5-6 mg oral weekly in studies|intermittent dosing protocols|clinical monitoring for tolerability

NMN Dosing

250-1000 mg/day oral|single or divided doses|daily supplementation in studies

Rapamycin Side Effects

  • mouth ulcers
  • elevated lipids
  • immunosuppression
  • glucose intolerance

NMN Side Effects

  • nausea
  • headache
  • GI discomfort
  • flushing

Research Overview

Rapamycin

Rapamycin extends lifespan in multiple model organisms and is a cornerstone compound in longevity biology. Human studies focus on immune function, inflammation, and age-related biomarkers rather than proven lifespan extension.

NMN

NMN has a substantial preclinical and growing human literature centered on raising NAD+ levels. Research is strongest for biomarker changes and metabolic endpoints, while long-term aging outcomes remain under investigation.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Rapamycin stacks with:

MetforminSpermidineNMN

NMN stacks with:

ResveratrolSpermidineRapamycin
mTORautophagygerosciencelongevityNAD+mitochondriaDNA-repair